India, Jan. 19 -- image credit- freepik

Syngene International, a global contract research, development, and manufacturing organization (CRDMO), has announced the extension of its long-standing strategic collaborationwithBristolMyersSquibbthrough2035.

Theexpanded agreementbroadensthescope of integrated services across the drug development lifecycle spanning discovery (chemistry, biology, drug metabolism and pharmacokinetics), translational sciences, pharmaceutical development and manufacturing,clinicaltrials,dataandinformationtechnologyservicestoenableseamlessprogression from research to commercialisation.

The expansion of this collaboration marks the next phase of growth, reinforcing Syngene's position as a strategic partner delivering...